Form 4: Nascent Biotech Director Douglas Karas Acquires Shares as Part of Employment Contract

Director Douglas Karas acquired 28,935 shares of Nascent Biotech Inc. common stock on December 29, 2023, as part of his employment contract.

Summary

• On December 29, 2023, Douglas Karas, a director of Nascent Biotech Inc., acquired 28,935 shares of common stock.
• The acquisition was part of his employment contract with the company.
• The price per share was $0.18.
• Following the transaction, Karas directly owns 1,744,452 shares of Nascent Biotech Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of an insider transaction related to an employment contract. It doesn't necessarily indicate positive or negative sentiment about the company's future performance.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Key Dates

Keywords

Nascent Biotech, NBIO, Douglas Karas, Director, Stock Acquisition, Employment Contract, Form 4, SEC Filing